Marker Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking

Marker Therapeutics, Inc. Website Screenshot

Marker Therapeutics, Inc. Company Intro

A major leap forward in cell therapy Marker Therapeutics Reports Update from TACTOPS Trial with MultiTAA-Specific T Cell Therapy in Pancreatic Cancer at ASCO20 View Press Release Here View Poster Here The Company We are a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications....



Marker Therapeutics, Inc. Headquaters

Phoenix Tower
United States

Marker Therapeutics, Inc. Share price

19 Jan 2021 02:07 GMT


0.01 (0.47 %)

Marker Therapeutics, Inc. Market cap

$99.412 M



Marker Therapeutics, Inc. # 275


Latest Marker Therapeutics, Inc. News

News 06 Jan 2021

Biotechnology Industry Should offer Path to MRKR stock

Piper Sandler rated the Marker Therapeutics Inc. (NASDAQ: MRKR) stock “a Neutral” and gave the company's common stock a price target of $2.50.

News 06 Jan 2021

FDA Lifts Partial Clinical Hold for Phase 2 Study of MT-401 in ...

... as treatment of patients with post-transplant acute myeloid leukemia (AML), announced Marker Therapeutics, Inc., developer of the drug, in a press release.

News 06 Jan 2021

BUZZ-U.S. STOCKS ON THE MOVE-AmerisourceBergen ...

O>, down 14% ** Sigilon Therapeutics Inc <SGTX. ... BUZZ-Jumps on promising data from COVID-19 treatment study ** Marker Therapeutics Inc MRKR.

WMC Market Score

WMC Market to Revenue Score

Marker Therapeutics, Inc. Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Marker Therapeutics, Inc. USD $680 $24,698 $-23,366 $994M 275
Regeneron Pharmaceuticals, Inc. USD $9,243,500 $5,152,600 $3,156,000 $552,660B 1
Alexion Pharmaceuticals, Inc. USD $5,862,400 $2,588,400 $956,600 $342,740B 2
Vertex Pharmaceuticals Incorporated USD $5,991,128 $2,596,854 $2,690,691 $586,520B 3
ALK-Abello A/S USD $3,383,000 $1,831,000 $43,000 $274,470B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Marker Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors

Marker Therapeutics, Inc. Post vs Top 4 Industry Competitors

Marker Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors

Marker Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors

Marker Therapeutics, Inc. WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Marker Therapeutics, Inc. 0.01 0.14 0 0 0 0 0.07
Regeneron Pharmaceuticals, Inc. 100 66.03 28.72 100 0 0 100
Alexion Pharmaceuticals, Inc. 63.42 16.18 100 60 0 0 90.52
Vertex Pharmaceuticals Incorporated 64.81 100 8.81 86 0 0 99.94
ALK-Abello A/S 36.60 0 0 0 0 0 0

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb